- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/7008 - Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
Patent holdings for IPC class A61K 31/7008
Total number of patents in this class: 659
10-year publication summary
|
51
|
49
|
50
|
42
|
44
|
44
|
50
|
30
|
26
|
7
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Amicus Therapeutics, Inc. | 353 |
17 |
| The Regents of the University of California | 20410 |
13 |
| FLE International S.r.l. | 39 |
10 |
| Société des Produits Nestlé S.A. | 9926 |
9 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 3256 |
8 |
| The Johns Hopkins University | 5777 |
7 |
| Centre National de La Recherche Scientifique | 10812 |
6 |
| Purepharm Inc. | 34 |
6 |
| Notogen, Inc. | 6 |
6 |
| Boehringer Ingelheim International GmbH | 4576 |
5 |
| Pfizer Inc. | 3373 |
5 |
| Farnam Companies, Inc. | 136 |
5 |
| Marine Polymer Technologies, Inc. | 62 |
5 |
| Tulex Pharmaceuticals Inc., DBA Tulex Pharmaceuticals Inc. | 21 |
5 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2947 |
5 |
| The University of Tokyo | 4297 |
5 |
| U.S. Nutraceuticals, L.L.C., DBA Valensa International | 26 |
5 |
| Nestec S.A. | 2612 |
4 |
| Arrowhead Pharmaceuticals, Inc. | 335 |
4 |
| Australian Biomedical Company Pty Ltd. | 5 |
4 |
| Other owners | 525 |